Recognizing the Pioneers in Down Syndrome Research – 2015 Awards Gala

STL Event LogoWe are so excited to be hosting our very first awards gala – The Sky’s the Limit – in Seattle on May 2, 2015.

We selected the Sky’s the Limit theme to represent the hope we feel. Thanks to your support over these 11 years, research that was once too complex to even consider is now experiencing tremendous breakthroughs. There are more discoveries, more exceptional, young researchers interested in pursuing careers in Down syndrome research, and interest from pharmaceutical firms to develop drug therapies.

Our inaugural event will honor five exceptional people who helped advance Down syndrome research. On Saturday evening, we will be presenting the following awards:

  • Founders’ Award – Presented to Jim White and Patty O’Brien White on behalf of all those who were a part of the creation of the organization. This is a legacy award to be presented in 2016 and beyond to those who make an impact to the advancement of research.
  • Dr. David Cox Rising Star Award – Presented to Dr. Jamie Edgin, University of Arizona
  • Dr. William Cohen Researcher of Distinction Award – Presented to Dr. William Mobley, University of California, San Diego
  • Luminary Award – Presented to Sarah Wernikoff, former Chairperson, LuMind Research Down Syndrome Foundation

About our Honorees:

Jamie Edgin websiteJamie Edgin, PhD, is an Assistant Professor in the Department of Psychology and the Sonoran UCEDD at the University of Arizona. Her research centers on studies of sleep and learning in Down syndrome, and she has been instrumental in devising new methods to measure cognition in those with Ds. Dr. Edgin serves on a number of community boards, including her service on the State of Arizona Developmental Disabilities Planning Council.

Dr. William Mobley, MD, PhD, is Distinguished Professor and Chair of the Department of Neurosciences at University of California, San Diego. He also serves as executive director of UCSD’s Down Syndrome Center for Research and Treatment. His research emphasis on the neurobiology of Down syndrome has brought new insights into Down syndrome, including possible therapies to improve cognition and unraveling the connections between Down syndrome and Alzheimer’s disease.

Sarah LinkedInSarah Wernikoff served as LuMind Board Chair from 2012-2014 and was a member of the LuMind board for 7 years. Her professional background includes over 15 years experience in ecommerce general business management, marketing strategy and planning, merchandising, and management consulting. Sarah has three children including an 11 year old daughter who has Down syndrome.

white_large croppedJim White and Patty Ann O’Brien White are accepting this award on behalf of all of the people who were a part of the creation of the organization eleven years ago. Jim is a Managing Director with Sutter Hill Ventures and Patty is a marketing consultant at GSVlabs. The Whites have four children, including a daughter with Down syndrome.

If you would like to support the event, we are accepting donations in honor of the award recipients or for the event. Please learn more on our event page.

A big thank you to Confluence Health for their sponsorship of the Gala.

One thought on “Recognizing the Pioneers in Down Syndrome Research – 2015 Awards Gala

  1. Jack

    Kudo to all the people, scientists and advocates for DS!
    However, I want to share with the DS community some serious concerns that I have after reading through the report on how the $ raised are invested in DS research.
    It is very unsettling for a lay person to realize that for the last 3 years the Lumind foundation has funded the same people, projects and labs!
    Is this the policy of the Foundation?
    Is it because there are no new research proposals submitted to the Foundation? Last time I checked the website gives instructions on how to apply for a grant.
    For me the situation stinks, since it looks like a little club of friends who automatically get the $ with no competition or questions asked (parenthetically 2 SAB members are also recipients of grants for the last 3 years).
    I strongly believe that as for any other field we need new ideas and new people on board to advance our understanding of the syndrome and most importantly to come up with a new viable drug or therapeutic approach for our children.
    It is time to stop the status quo!
    I would like to know the opinion of others on this very important topic.

    Reply

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s